Chemomab Therapeutics (CMMB) Tax Provisions (2018 - 2023)

Name: Chemomab Therapeutics (CMMB) Tax Provisions (2018 - 2023) | Business Quant
Creator: Business Quant

Chemomab Therapeutics posted quarterly Tax Provisions of -$55000.0 for Q3 2023, down 261.76% on a QoQ basis from $34000.0 in Q2 2023.

Chemomab Therapeutics (CMMB) has 4 years of Tax Provisions data on file, last reported at -$55000.0 in Q3 2023.

For the quarter ending Q3 2023, Tax Provisions changed N/A year-over-year to -$55000.0; the trailing twelve-month figure through Sep 2023 stood at $10000.0 (up 101.84% YoY), and the FY2022 full-year result was -$534000.0, changed N/A from the prior year.
Tax Provisions for Q3 2023 stood at -$55000.0, down from $34000.0 in the prior quarter.
Across five years, Tax Provisions topped out at $34000.0 in Q2 2023 and bottomed at -$544000.0 in Q2 2022.
The 3-year median for Tax Provisions is -$22500.0 (2022), against an average of -$161166.7.
The widest annual swing landed in 2019, when Tax Provisions sank 736.76%; it then surged 106.25% in 2023.
A 3-year view of Tax Provisions shows it stood at -$433000.0 in 2019, then soared by 102.31% to $10000.0 in 2022, then sank by 650.0% to -$55000.0 in 2023.
The last three Tax Provisions figures came in at -$55000.0 (Q3 2023), $34000.0 (Q2 2023), and $21000.0 (Q1 2023), per Business Quant data.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Quantum Biopharma	961,148.99 Bn	961,148.98 Bn	-	-
2	Alterity Therapeutics	744,933.29 Bn	744,933.26 Bn	-	-
3	Legend Biotech	2,540.00 Bn	2,539.71 Bn	242.10 Mn	-11.20 Mn
4	Nanobiotix	2,199.85 Bn	2,199.78 Bn	-	-
5	Akari Therapeutics	1,635.88 Bn	1,635.88 Bn	-	-859,000.00
6	Vertex Pharmaceuticals	111.32 Bn	104.07 Bn	2.59 Bn	221.50 Mn
7	Evaxion A	62.56 Bn	62.54 Bn	-	216,000.00
8	Regeneron Pharmaceuticals	62.55 Bn	53.79 Bn	3.31 Bn	104.00 Mn
9	Alnylam Pharmaceuticals	39.57 Bn	36.56 Bn	959.66 Mn	15.66 Mn
10	Chemomab Therapeutics	959.23 Mn	948.86 Mn	-	-

Download Data 🔒